Head and neck soft tissue sarcomas: 40 Year casuistry from ENT Department of IPO-LFG
DOI:
https://doi.org/10.34631/sporl.2072Keywords:
sarcomas, head and neck, tumorsAbstract
Objective: To identify prognostic factors for Head and Neck Soft Tissue Sarcoma. Assess survival according to sublocation and treatment.Study design: Observational retrospective study
Material/methods: Analysis of patients data with Head and Neck Soft Tissue Sarcoma followed at the ENT department at IPO-LFG between 1980 and 2022.
Results: 59 patients (64% men) with a mean age of 47,2 years were selected. Chondrosarcoma and rhabdomyosarcoma were the most diagnosed and the larynx was the most affected local. 83% were operated; 28%% relapsed locally; and 10% had metastasis. 17% of patients died from the disease. The patients who received RT exclusively died. The disease-specific survival rate at the 5th year was 83%, with the spindle cell sarcoma having the worst results.
Conclusion: Head and Neck Sarcomas have worse outcomes than other locations. Spindle cell sarcoma and primary treatment with RT were associated with higher mortality. Early surgical treatment is essential.
References
Kotecha S, Williams MA, White HB, Graystone J, Gibbons M, Cosker T. Head and neck sarcoma: three-year data from a tertiary referral centre. Ann R Coll Surg Engl. 2021 Nov;103(10):762-767. DOI: https://doi.org/10.1308/rcsann.2021.0119.
Aljabab AS, Nason RW, Kazi R, Pathak KA. Head and neck soft tissue sarcoma. Indian J Surg Oncol. 2011 Dec;2(4):286-90. DOI: https://doi.org/10.1007/s13193-012-0127-5.
Scelsi CL, Wang A, Garvin CM, Bajaj M, Forseen SE, Gilbert BC. Head and neck sarcomas: review of clinical and imaging findings based on the 2013 World Health Organization Classification. AJR Am J Roentgenol. 2019 Mar;212(3):644-654. DOI: https://doi.org/10.2214/AJR.18.19894.
Tejani MA, Galloway TJ, Lango M, Ridge JA, von Mehren M. Head and neck sarcomas: a comprehensive cancer center experience. Cancers (Basel). 2013 Jul 15;5(3):890-900. DOI: https://doi.org/10.3390/cancers5030890
Wanebo HJ. Head and neck sarcoma. In: Johnson JT, Didolker MS, editors. Head and neck cancer. Amsterdam: Elsevier Science; 1993. p. 39-47
Patel SG, Shaha AR, Shah JP. Soft tissue sarcoma of the head and neck: an update. Am J Otolaryngol. 2001 Jan-Feb;22(1):2-18. DOI: https://doi.org/10.1053/ajot.2001.20699.
Heslin MJ, Lewis JJ, Woodruff JM, Brennan MF. Core needle biopsy for diagnosis of extremity soft tissue sarcoma. Ann Surg Oncol. 1997 Jul-Aug;4(5):425-31. DOI: https://doi.org/10.1007/BF02305557.
Tran LM, Mark R, Meier R, Calcaterra TC, Parker RG. Sarcoma of the head and neck, prognostic factors and treatment strategies. Cancer. 1992 Jul 1;70(1):169-77. DOI: https://doi.org/10.1002/1097-0142(19920701)70:1<169::aid-cncr2820700127>3.0.co;2-f.
Link MP, Goorin AM, Miser AW, Green AA, Pratt CB, Belasco JB et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of extremity. N Engl J Med. 1986 Jun 19;314(25):1600-6. DOI: https://doi.org/10.1056/NEJM198606193142502.
Jeannon JP, Irish J, Osullivan B, Goh C, Brown DH, Neligan P. et al. Adult soft tissue sarcomas of the head and neck. Asian J Surg. 2002 Jan;25(1):5-12.
Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS. et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1,225 patients. Cancer. 2003 May 15;97(10):2530-43. DOI: https://doi.org/10.1002/cncr.11365.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Portuguese Journal of Otorhinolaryngology and Head and Neck Surgery
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
